Inpatient management of atopic dermatitis

Dermatologic Therapy

Volumn 24, Issue 2, 2011, Pages 249-255

  Cathcart, Shelley D ^a   Theos, Amy ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Atopic dermatitis; Eczema herpeticum; Erythroderma; Hospitalized patient; Wet wrap therapy

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BETAMETHASONE VALERATE; CORTICOSTEROID; DESONIDE; EMOLLIENT AGENT; FAMCICLOVIR; FLUTICASONE PROPIONATE; HYDROCORTISONE; MOMETASONE FUROATE; TRIAMCINOLONE; VALACICLOVIR;

ATOPIC DERMATITIS; BACTERIAL INFECTION; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ERYTHRODERMA; HOSPITAL PATIENT; HUMAN; KAPOSI VARICELLIFORM ERUPTION; NONHUMAN; PATIENT COMPLIANCE; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT INDICATION;

DERMATITIS, ATOPIC; DERMATOLOGY; HOSPITALS; HUMANS; INPATIENTS; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; RISK FACTORS; SKIN; TREATMENT OUTCOME;

EID: 79952740498     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2011.01400.x     Document Type: Review

References (25)

1. Laughter D, Istvan JA, Tofte SJ, et al. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000: 43: 649-655.
2. Sterry W, Assaf C. Erythroderma. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Philadelphia PA: Elsevier, 2008: 149-158.
3. Katoh N, Hosoi H, Sugimoto T, et al. Features andprognoses of infantile patients with atopic dermatitis hospitalized for serious complications. J Dermatol 2006: 12: 827-832. (Pubitemid 44813780)
4. Lee JH, Lee SJ, Kim DS, et al. The effect of wetwrap dressing on epidermal barrier in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2007: 21: 1360-1368. (Pubitemid 350020143)
5. Oranje AP, Devillers ACA, Kunz B, et al. Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature. J Eur Acad Dermatol Venereol 2006: 20: 1277-1286.
6. Schnopp C, Holtmann C, Stock S, et al. Topical steroids under wet-wrap dressings in atopic dermatitis - a vehicle-controlled trial. Dermatology 2002: 204: 56-59. (Pubitemid 34136815)
7. Goodyear HM, Spowart K, Harper JI. "Wet wrap" dressings for the treatment of atopic eczema in children. Br J Dermatol 1991: 125: 604.
8. Devillers ACA, de Waard van der Spek FB, Mulder PGH, et al. Treatment of refractory atopic dermatitis using "wet-wrap" dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology 2002: 204: 50-55.
9. Wolkerstorfer A, Visser RL, de Waard van der Spek FB, et al. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution. Br J Dermatol 2000: 143: 999-1004.
10. Pei AY, Chan HH, Ho KM. The effectiveness of "wet wrap" dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatr Dermatol 2001: 18: 343-348.
11. Wheeler CE Jr, Abele DC. Eczema herpeticum, primary and recurrent. Arch Dermatol 1966: 93: 162-173.
12. Sanderson IR, Brueton LA, Savage MO, et al. Eczema herpeticum: a potentially fatal disease. Br Med J 1987: 294: 693-694. (Pubitemid 17041974)
13. Wollenberg A, Wetzel S, Burgdorf WH, et al. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003: 112: 667-674. (Pubitemid 37260380)
14. Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 2009: 124: 260-269.
15. Wollenberg A, Zoch C, Wetzel S, Plewig G, et al. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol 2003: 49: 198-205. (Pubitemid 36951264)
16. Krusinski P. Kaposi varicelliform eruption. eMedicine. http://emedicine.medscape.com/article/11362. Accessed May 11, 2010. Last updated Dec 3, 2009.
17. Paller AS, Mancini AJ. Eczematous eruptions in childhood. In:Hurwitz clinical pediatric dermatology, 3rd ed. Philadelphia, PA: Elsevier, 2006: 49-84.
18. Kramer SC, Thomas CJ, Tyler WB, et al. Kaposi's varicelliform eruption: a case report and review of the literature. Cutis 2004: 73: 115-122. (Pubitemid 38326413)
19. Bork K, Brauninger W. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 1988: 19: 1024-1029. (Pubitemid 19001528)
20. Leyden JJ, Marples RR, Klingman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974: 90: 525-530.
21. Marples RR, Heaton C, Klingman AM. Staphylococcus aureus in psoriasis. Arch Dermatol 1973: 107: 568-570.
22. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002: 347: 1151-1160.
23. Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009: 123: e808-e814.
24. Benenson S, Zimhony O, Dahan D, et al. Atopic dermatitis - a risk factor for invasive Staphylococcus aureus infections: two cases and review. Am J Med 2005: 118: 1048-1051. (Pubitemid 41297773)
25. Skiest DJ, Brown K, Cooper TW, et al. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007: 54: 427-434. (Pubitemid 46567511)